Three-dimensional conformal intensity modulation: Clinical Trials

1 trial of Three-dimensional conformal intensity modulation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Three-dimensional conformal intensity modulation: new trials by email Literature Review of Three-dimensional conformal intensity modulation trials Research Report on Three-dimensional conformal intensity modulation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Radiotherapy Combined With Apatinib Mesylate in the Treatment of Rhabdomyosarcoma in Children
Apatinib mesylate tablets, Three-dimensional conformal intensity modulation - Childhood Rhabdomyosarcoma
Phase 1 / Phase 2UnknownXinhua Hospital, Shanghai Jiao Tong University School of Medicine482019-01-012019-03-11

Sponsors

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (1)

Countries

China (1)

Top investigators

Mawei Jiang, MD (1)

Results publications

PMID 32827353